angiotensin ii has been researched along with metallothionein in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brady, FO; Funk, AE; Garrett, SH; Helvig, BS | 1 |
Brady, FO; Helvig, BS | 1 |
Krämer, K; Markwitan, A; Pallauf, J | 1 |
Epstein, PN; Metreveli, NS; Ren, J; Ye, G | 1 |
Cai, L; Hein, DW; Li, X; Marshall, JP; Prabhu, SD; Xiang, X; Zhou, G | 1 |
De Mello, WC | 1 |
Cai, L; Liu, Q; Tan, Y; Wang, G; Wang, Y; Xu, J; Xu, W | 1 |
Cai, L; Feng, W; Liu, L; Liu, Q; Tan, Y; Wang, G; Wang, X; Wei, W; Xue, W; Zhou, G | 1 |
8 other study(ies) available for angiotensin ii and metallothionein
Article | Year |
---|---|
The involvement of catecholamines and polypeptide hormones in the multihormonal modulation of rat hepatic zinc thionein levels.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Catecholamines; Cyclic AMP; Dexamethasone; Enzyme Activation; Female; Glucagon; Inflammation; Liver; Male; Metallothionein; Phorbol Esters; Protein Kinase C; Protein Kinases; Rats; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Turpentine; Type C Phospholipases | 1987 |
Effects of glucagon, Arg-vasopressin, and angiotensin II on rat hepatic zinc thionein levels.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Chlorobutanol; Dexamethasone; Epinephrine; Glucagon; Liver; Male; Metallothionein; Rats; Rats, Inbred Strains; Zinc | 1984 |
Studies on the metabolism of metallothionein and alkaline phosphatase of adult rat primary hepatocyte cultures: role of fetal calf serum and agonists of the phosphoinositide cascade.
Topics: Alkaline Phosphatase; Angiotensin II; Animals; Arginine Vasopressin; Calcimycin; Cells, Cultured; Culture Media; Dexamethasone; Diglycerides; Liver; Metallothionein; Phosphatidylinositols; Platelet Activating Factor; Rats; Tetradecanoylphorbol Acetate; Zinc | 1993 |
Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Diabetes Complications; Diabetes Mellitus; Enzyme Inhibitors; Gene Expression; Glucose; Losartan; Metallothionein; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; NADPH Oxidases; Onium Compounds; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Spectrometry, Fluorescence | 2003 |
Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomyopathies; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Fibrosis; Hypertrophy; Metallothionein; Mice; Mice, Transgenic; Myocardium; Myocytes, Cardiac; NADP; Oxidative Stress; Ventricular Remodeling | 2008 |
Metallothionein reverses the harmful effects of angiotensin II on the diabetic heart.
Topics: Angiotensin II; Cardiomyopathies; Diabetic Angiopathies; Humans; Metallothionein; NADP; Oxidative Stress | 2008 |
Diabetes- and angiotensin II-induced cardiac endoplasmic reticulum stress and cell death: metallothionein protection.
Topics: Angiotensin II; Animals; Antioxidants; Cell Death; Cells, Cultured; Cytoprotection; Diabetes Mellitus, Experimental; Endoplasmic Reticulum; Humans; Metallothionein; Mice; Mice, Transgenic; Molecular Chaperones; Myocardium; Rats; Stress, Physiological; Tunicamycin; Up-Regulation | 2009 |
Angiotensin II-induced p53-dependent cardiac apoptotic cell death: its prevention by metallothionein.
Topics: Angiotensin II; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Cell Death; Cells, Cultured; DNA Damage; DNA Fragmentation; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; Metallothionein; Mice; Myocardium; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rats; Tumor Suppressor Protein p53 | 2009 |